Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
AbbVie Inc has a consensus price target of $176.56 based on the ratings of 29 analysts. The high is $218 issued by Morgan Stanley on August 12, 2024. The low is $133 issued by CFRA on February 9, 2023. The 3 most-recent analyst ratings were released by Piper Sandler, Morgan Stanley, and Cantor Fitzgerald on August 23, 2024, August 12, 2024, and August 5, 2024, respectively. With an average price target of $209 between Piper Sandler, Morgan Stanley, and Cantor Fitzgerald, there's an implied 6.36% upside for AbbVie Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for AbbVie (NYSE:ABBV) was reported by Piper Sandler on August 23, 2024. The analyst firm set a price target for $209.00 expecting ABBV to rise to within 12 months (a possible 6.36% upside). 34 analyst firms have reported ratings in the last year.
The latest analyst rating for AbbVie (NYSE:ABBV) was provided by Piper Sandler, and AbbVie maintained their overweight rating.
The last upgrade for AbbVie Inc happened on June 5, 2024 when HSBC raised their price target to $185. HSBC previously had a hold for AbbVie Inc.
The last downgrade for AbbVie Inc happened on December 18, 2023 when HSBC changed their price target from $167 to $156 for AbbVie Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AbbVie, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AbbVie was filed on August 23, 2024 so you should expect the next rating to be made available sometime around August 23, 2025.
While ratings are subjective and will change, the latest AbbVie (ABBV) rating was a maintained with a price target of $196.00 to $209.00. The current price AbbVie (ABBV) is trading at is $196.50, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.